Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

Cumulative Risk of End-Stage Renal Disease Among Patients With Type 2 Diabetes: A Nationwide Inception Cohort Study.

Finne P, Groop PH, Arffman M, Kervinen M, Helve J, Grönhagen-Riska C, Sund R.

Diabetes Care. 2019 Apr;42(4):539-544. doi: 10.2337/dc18-1485. Epub 2019 Jan 28.

PMID:
30692239
2.

Type 2 diabetic patients on renal replacement therapy: Probability to receive renal transplantation and survival after transplantation.

Kervinen MH, Lehto S, Helve J, Grönhagen-Riska C, Finne P.

PLoS One. 2018 Aug 15;13(8):e0201478. doi: 10.1371/journal.pone.0201478. eCollection 2018.

3.

Factors associating with differences in the incidence of renal replacement therapy among elderly: data from the ERA-EDTA Registry.

Helve J, Kramer A, Abad-Diez JM, Couchoud C, de Arriba G, de Meester J, Evans M, Glaudet F, Grönhagen-Riska C, Heaf JG, Lezaic V, Nordio M, Palsson R, Pechter Ü, Resic H, Santamaria R, Santiuste de Pablos C, Massy ZA, Zurriaga Ó, Jager KJ, Finne P.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1428-1435. doi: 10.1093/ndt/gfy056.

PMID:
29684185
4.

One- and 2-Year Mortality Prediction for Patients Starting Chronic Dialysis.

Haapio M, Helve J, Grönhagen-Riska C, Finne P.

Kidney Int Rep. 2017 Jun 24;2(6):1176-1185. doi: 10.1016/j.ekir.2017.06.019. eCollection 2017 Nov.

5.

Incidence of End-Stage Renal Disease in Patients With Type 1 Diabetes.

Helve J, Sund R, Arffman M, Harjutsalo V, Groop PH, Grönhagen-Riska C, Finne P.

Diabetes Care. 2018 Mar;41(3):434-439. doi: 10.2337/dc17-2364. Epub 2017 Dec 20.

PMID:
29263163
6.

Biochemical variables and survival of patients with type 1 diabetes on renal replacement therapy.

Helve J, Haapio M, Groop PH, Grönhagen-Riska C, Finne P.

Blood Purif. 2014;38(1):18-23. doi: 10.1159/000362861. Epub 2014 Sep 13.

PMID:
25228237
7.

Pretransplant dialysis duration and risk of death after kidney transplantation in the current era.

Helanterä I, Salmela K, Kyllönen L, Koskinen P, Grönhagen-Riska C, Finne P.

Transplantation. 2014 Aug 27;98(4):458-64. doi: 10.1097/TP.0000000000000085.

PMID:
24646770
8.

Medication among patients with type 1 diabetes and predialytic renal disease.

Helve J, Sund R, Haapio M, Groop PH, Grönhagen-Riska C, Finne P.

Diabetes Res Clin Pract. 2014 Mar;103(3):510-5. doi: 10.1016/j.diabres.2013.12.010. Epub 2013 Dec 25.

PMID:
24423442
9.

Modality of chronic renal replacement therapy and survival--a complete cohort from Finland, 2000-2009.

Haapio M, Helve J, Kyllönen L, Grönhagen-Riska C, Finne P.

Nephrol Dial Transplant. 2013 Dec;28(12):3072-81. doi: 10.1093/ndt/gft326. Epub 2013 Sep 12.

PMID:
24030833
10.

New primary renal diagnosis codes for the ERA-EDTA.

Venkat-Raman G, Tomson CR, Gao Y, Cornet R, Stengel B, Gronhagen-Riska C, Reid C, Jacquelinet C, Schaeffner E, Boeschoten E, Casino F, Collart F, De Meester J, Zurriaga O, Kramar R, Jager KJ, Simpson K; ERA-EDTA Registry.

Nephrol Dial Transplant. 2012 Dec;27(12):4414-9. doi: 10.1093/ndt/gfs461. Epub 2012 Nov 22.

11.

Effect of vascular comorbidities on survival of type 2 diabetes patients on renal replacement therapy.

Kervinen M, Lehto S, Grönhagen-Riska C, Finne P.

Am J Nephrol. 2012;36(6):509-15. doi: 10.1159/000345143. Epub 2012 Nov 17.

12.

Employment of patients receiving maintenance dialysis and after kidney transplant: a cross-sectional study from Finland.

Helanterä I, Haapio M, Koskinen P, Grönhagen-Riska C, Finne P.

Am J Kidney Dis. 2012 May;59(5):700-6. doi: 10.1053/j.ajkd.2011.08.025. Epub 2011 Sep 29.

PMID:
21958597
13.

Decline in the incidence of renal failure due to amyloidosis associated with inflammatory rheumatic diseases.

Immonen K, Pettersson T, Finne P, Grönhagen-Riska C, Klaukka T, Kautiainen H, Hakala M.

Amyloid. 2011 Jun;18 Suppl 1:229-30. doi: 10.3109/13506129.2011.574354086. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:230.

PMID:
21838498
14.

Decline in glomerular filtration rate during pre-dialysis phase and survival on chronic renal replacement therapy.

Haapio M, Helve J, Kurimo P, Forslund T, Grönhagen-Riska C, Finne P.

Nephrol Dial Transplant. 2012 Mar;27(3):1157-63. doi: 10.1093/ndt/gfr423. Epub 2011 Aug 1.

PMID:
21810761
15.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators.

Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12.

16.

Comorbidities and survival of patients with type 1 diabetes on renal replacement therapy.

Helve J, Haapio M, Groop PH, Grönhagen-Riska C, Finne P.

Diabetologia. 2011 Jul;54(7):1663-9. doi: 10.1007/s00125-011-2140-6. Epub 2011 Apr 5.

PMID:
21465326
17.

A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland.

Immonen K, Finne P, Grönhagen-Riska C, Pettersson T, Klaukka T, Kautiainen H, Hakala M.

Amyloid. 2011 Mar;18(1):25-8. doi: 10.3109/13506129.2010.549252. Epub 2011 Feb 1.

PMID:
21284495
18.

Survival of patients with type 1 diabetes receiving renal replacement therapy in 1980-2007.

Haapio M, Helve J, Groop PH, Grönhagen-Riska C, Finne P.

Diabetes Care. 2010 Aug;33(8):1718-23. doi: 10.2337/dc10-0030. Epub 2010 Apr 30.

19.

Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland.

Kastarinen M, Juutilainen A, Kastarinen H, Salomaa V, Karhapää P, Tuomilehto J, Grönhagen-Riska C, Jousilahti P, Finne P.

J Intern Med. 2010 Jun;267(6):612-20. doi: 10.1111/j.1365-2796.2009.02197.x. Epub 2010 Nov 19.

20.

Improved survival of type 2 diabetic patients on renal replacement therapy in Finland.

Kervinen M, Lehto S, Ikäheimo R, Karhapää P, Grönhagen-Riska C, Finne P.

Nephrol Dial Transplant. 2010 Mar;25(3):892-6. doi: 10.1093/ndt/gfp555. Epub 2009 Oct 21.

PMID:
19846391
21.

An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.

Kramer A, Stel V, Zoccali C, Heaf J, Ansell D, Grönhagen-Riska C, Leivestad T, Simpson K, Pálsson R, Postorino M, Jager K; ERA-EDTA Registry.

Nephrol Dial Transplant. 2009 Dec;24(12):3557-66. doi: 10.1093/ndt/gfp519. Epub 2009 Oct 9.

PMID:
19820003
22.

Inflammation in renal transplantation.

Abedini S, Holme I, März W, Weihrauch G, Fellström B, Jardine A, Cole E, Maes B, Neumayer HH, Grønhagen-Riska C, Ambühl P, Holdaas H; ALERT study group.

Clin J Am Soc Nephrol. 2009 Jul;4(7):1246-54. doi: 10.2215/CJN.00930209. Epub 2009 Jun 18.

23.

The Nephrocare project: referral, patient case-mix, follow-up and quality of renal care in Nordic renal centres.

Bergrem H, Gøransson LG, Asmundsson P, Feldt-Rasmussen B, Grønhagen-Riska C, Westberg G.

Scand J Urol Nephrol. 2009;43(4):319-24. doi: 10.1080/00365590902833697.

PMID:
19333821
24.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group.

N Engl J Med. 2009 Apr 2;360(14):1395-407. doi: 10.1056/NEJMoa0810177. Epub 2009 Mar 30. Erratum in: N Engl J Med. 2010 Apr 15;362(15):1450.

25.

Is Cystatin C more sensitive than creatinine in detecting early chronic allograft nephropathy?

Ortiz F, Harmoinen A, Paavonen T, Koskinen P, Grönhagen-Riska C, Honkanen E.

Clin Nephrol. 2008 Jul;70(1):18-25.

PMID:
18793544
26.

No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases -- data from the Finnish national registry for kidney diseases.

Immonen K, Finne P, Hakala M, Kautiainen H, Pettersson T, Grönhagen-Riska C.

J Rheumatol. 2008 Jul;35(7):1334-8. Epub 2008 Apr 15.

PMID:
18609734
27.

Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy.

Lauhio A, Sorsa T, Srinivas R, Stenman M, Tervahartiala T, Stenman UH, Grönhagen-Riska C, Honkanen E.

Ann Med. 2008;40(4):312-20. doi: 10.1080/07853890801923746.

PMID:
18428024
28.

IL5RA and TNFRSF6B gene variants are associated with sporadic IgA nephropathy.

Liu XQ, Paterson AD, He N, St George-Hyslop P, Rauta V, Gronhagen-Riska C, Laakso M, Thibaudin L, Berthoux F, Cattran D, Pei Y.

J Am Soc Nephrol. 2008 May;19(5):1025-33. doi: 10.1681/ASN.2007091013. Epub 2008 Feb 6.

29.

International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality.

Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL, Port FK, Jager KJ, Homel P, Augustijn H, de Charro FT, Collart F, Erek E, Finne P, Garcia-Garcia G, Grönhagen-Riska C, Ioannidis GA, Ivis F, Leivestad T, Løkkegaard H, Lopot F, Jin DC, Kramar R, Nakao T, Nandakumar M, Ramirez S, van der Sande FM, Schön S, Simpson K, Walker RG, Zaluska W, Levin NW.

J Am Soc Nephrol. 2006 Dec;17(12):3510-9. Epub 2006 Nov 15.

30.

Tyypin 1 diabetes ja krooninen munuaistauti.

Finne P, Grönhagen-Riska C.

Duodecim. 2006;122(12):1415-6. Finnish. No abstract available.

PMID:
17091666
31.

Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival.

Helanterä I, Koskinen P, Finne P, Loginov R, Kyllönen L, Salmela K, Grönhagen-Riska C, Lautenschlager I.

Transpl Int. 2006 Nov;19(11):893-900.

32.

[IgA nephropathy: from predicting progression to treatment].

Rauta V, Grönhagen-Riska C.

Duodecim. 2006;122(2):215-22. Review. Finnish. No abstract available.

PMID:
16509071
33.

[Future challenges for the care and treatment of kidney disease].

Finne P, Honkanen E, Grönhagen-Riska C.

Duodecim. 2006;122(2):193-5. Review. Finnish. No abstract available.

PMID:
16509067
34.

Increased urinary excretion of transforming growth factor-beta(1) in renal transplant recipients during cytomegalovirus infection.

Helanterä I, Teppo AM, Koskinen P, Törnroth T, Grönhagen-Riska C, Lautenschlager I.

Transpl Immunol. 2006 Jan;15(3):217-21. Epub 2005 Dec 22.

PMID:
16431289
35.

Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study.

Holdaas H, Fellström B, Cole E, Nyberg G, Olsson AG, Pedersen TR, Madsen S, Grönhagen-Riska C, Neumayer HH, Maes B, Ambühl P, Hartmann A, Staffler B, Jardine AG; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators.

Am J Transplant. 2005 Dec;5(12):2929-36. Erratum in: Am J Transplant. 2006 Aug;6(8):1986.

36.
37.

Incidence of end-stage renal disease in patients with type 1 diabetes.

Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C.

JAMA. 2005 Oct 12;294(14):1782-7.

PMID:
16219881
38.

Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane?

Martikainen TA, Teppo AM, Grönhagen-Riska C, Ekstrand AV.

Perit Dial Int. 2005 Sep-Oct;25(5):453-60.

PMID:
16178478
39.

Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.

Jardine AG, Fellström B, Logan JO, Cole E, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Pedersen T, Holdaas H.

Am J Kidney Dis. 2005 Sep;46(3):529-36.

PMID:
16129216
40.

Benefit of glucose-free dialysis solutions on glucose and lipid metabolism in peritoneal dialysis patients.

Martikainen T, Teppo AM, Gronhagen-Riska C, Ekstrand A.

Blood Purif. 2005;23(4):303-10. Epub 2005 Jun 23.

PMID:
15980620
41.

Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.

Piiparinen H, Helanterä I, Lappalainen M, Suni J, Koskinen P, Grönhagen-Riska C, Lautenschlager I.

J Med Virol. 2005 Jul;76(3):367-72.

PMID:
15902704
42.

Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial.

Fellström B, Jardine AG, Soveri I, Cole E, Grönhagen-Riska C, Neumayer HH, Maes B, Gimpelewicz C, Holdaas H; Assessment of Lescol in Renal Transplantation trial.

Transplantation. 2005 May 15;79(9):1160-3.

PMID:
15880062
43.

Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.

Holdaas H, Fellström B, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Logan JO, Staffler B, Gimpelewicz C; ALERT Study Group.

Nephrol Dial Transplant. 2005 May;20(5):974-80. Epub 2005 Mar 22.

44.

Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000).

Van Dijk PC, Jager KJ, Stengel B, Grönhagen-Riska C, Feest TG, Briggs JD.

Kidney Int. 2005 Apr;67(4):1489-99.

45.

Persistent cytomegalovirus infection is associated with increased expression of TGF-beta1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts.

Helanterä I, Loginov R, Koskinen P, Törnroth T, Grönhagen-Riska C, Lautenschlager I.

Nephrol Dial Transplant. 2005 Apr;20(4):790-6. Epub 2005 Feb 16.

PMID:
15716293
46.

The role of cytomegalovirus infection in chronic allograft nephropathy.

Helanterä I, Loginov R, Lautenschlager I, Helanterä I, Koskinen P, Törnroth T, Grönhagen-Riska C.

Transplantation. 2005 Feb 15;79(3):379. No abstract available.

PMID:
15699779
47.

Predictors of renal allograft histologic damage progression.

Ortiz F, Paavonen T, Törnroth T, Koskinen P, Finne P, Salmela K, Kyllönen L, Grönhagen-Riska C, Honkanen E.

J Am Soc Nephrol. 2005 Mar;16(3):817-24. Epub 2005 Feb 2.

48.

Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial.

Fellström B, Holdaas H, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Staffler B, Pedersen TR; Assessment of Lescol in Renal Transplantation Study Investigators.

Transplantation. 2005 Jan 27;79(2):205-12.

PMID:
15665769
49.

Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial.

Fellström B, Holdaas H, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Logan JO, Pedersen TR; Assessment of Lescol in Renal Transplantation Study Investigators.

Kidney Int. 2004 Oct;66(4):1549-55.

Supplemental Content

Loading ...
Support Center